Investors

INMODE IS A LEADING GLOBAL PROVIDER OF INNOVATIVE, ENERGY-BASED,
MINIMALLY AND NON-INVASIVE MEDICAL SOLUTIONS

InMode Ltd. (Nasdaq: INMD) is a leading global provider of innovative medical technologies. InMode develops, manufacturers, and markets devices harnessing novel radio-frequency (RF) based devices that strives to enable new emerging surgical procedures as well as improve existing treatments. InMode has leveraged its medically accepted minimally invasive RF technologies to offer a comprehensive line of products across several categories for plastic surgery, gynecology, dermatology, otolaryngology and ophthalmology.

STOCK PERFORMANCE

NASDAQ : INMD

PRICE

$0

CHANGE

0(0%)

VOLUME

0

Copyright Nasdaq. Latest trading day: .

Press Releases

InMode Receives Health Canada Certification of Forma-I for Dry Eye Disease Due to Meibomian Gland Dysfunction

InMode to Present at Upcoming Investor Conferences Before the End of 2022

InMode Reports Third Quarter 2022 Financial Results; Record Quarterly Revenue of $121.2 M, Represents 29% Year-Over-Year Growth

Financials & Filings

GET STARTED

Which technology is right for you?

Contact Us
Contact Us

Contact Us